Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Isoprenaline and quinidine to calm Brugada VF storm.

Literature DB >> 22891011

Isoprenaline and quinidine to calm Brugada VF storm.

Abstract

A 3-year-old man with an implanted cardioverter-defibrillator (ICD) for type 2 Brugada syndrome was admitted to coronary care unit with ventricular fibrillation electrical storm and consequent appropriate recurrent ICD shocks. The rhythm did not settle with conventional antiarrhythmics such as β-blockers and amiodarone. An isoprenaline infusion was set up with immediate stabilisation of rhythm. After a period of monitoring, the infusion was stopped and oral quinidine was started. He has remained free of problems for 1 year. This case-report summarises these novel treatments for electrical storm in Brugada syndrome and the mechanism behind them.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2012 PMID： 22891011 PMCID： PMC3433527 DOI： 10.1136/bcr.04.2011.4156

Source DB: PubMed Journal: BMJ Case Rep ISSN： 1757-790X

7 in total

1. Electrical storm in Brugada syndrome successfully treated using isoprenaline.

Authors: P Maury; P Couderc; M Delay; S Boveda; J Brugada
Journal: Europace Date: 2004-03 Impact factor: 5.214

2. Electrical storm in Brugada syndrome successfully treated with orciprenaline; effect of low-dose quinidine on the electrocardiogram.

Authors: Konstantinos Kyriazis; Edda Bahlmann; Hendrik van der Schalk; Karl-Heinz Kuck
Journal: Europace Date: 2009-04-03 Impact factor: 5.214

3. "Brugada" syndrome: clinical data and suggested pathophysiological mechanism.

Authors: M Alings; A Wilde
Journal: Circulation Date: 1999-02-09 Impact factor: 29.690

4. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation.

Authors: G X Yan; C Antzelevitch
Journal: Circulation Date: 1999-10-12 Impact factor: 29.690

Review 5. Efficacy of quinidine in high-risk patients with Brugada syndrome.

Authors: Bernard Belhassen; Aharon Glick; Sami Viskin
Journal: Circulation Date: 2004-09-20 Impact factor: 29.690

6. Electrical storms in Brugada syndrome successfully treated with isoproterenol infusion and quinidine orally.

Authors: J K Jongman; N Jepkes-Bruin; A R Ramdat Misier; W P Beukema; P P H M Delnoy; H Oude Lutttikhuis; J H E Dambrink; J C A Hoorntje; A Elvan
Journal: Neth Heart J Date: 2007 Impact factor: 2.380

7. Idiopathic ventricular fibrillation: inducibility and beneficial effects of class I antiarrhythmic agents.

Authors: B Belhassen; I Shapira; D Shoshani; A Paredes; H Miller; S Laniado
Journal: Circulation Date: 1987-04 Impact factor: 29.690

7 in total

9 in total

Review 1. J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Authors: Charles Antzelevitch; Gan-Xin Yan; Michael J Ackerman; Martin Borggrefe; Domenico Corrado; Jihong Guo; Ihor Gussak; Can Hasdemir; Minoru Horie; Heikki Huikuri; Changsheng Ma; Hiroshi Morita; Gi-Byoung Nam; Frederic Sacher; Wataru Shimizu; Sami Viskin; Arthur A M Wilde
Journal: Europace Date: 2017-04-01 Impact factor: 5.214

Isoprenaline and quinidine to calm Brugada VF storm.

1. Electrical storm in Brugada syndrome successfully treated using isoprenaline.

2. Electrical storm in Brugada syndrome successfully treated with orciprenaline; effect of low-dose quinidine on the electrocardiogram.

3. "Brugada" syndrome: clinical data and suggested pathophysiological mechanism.

4. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation.

Review 5. Efficacy of quinidine in high-risk patients with Brugada syndrome.

6. Electrical storms in Brugada syndrome successfully treated with isoproterenol infusion and quinidine orally.

7. Idiopathic ventricular fibrillation: inducibility and beneficial effects of class I antiarrhythmic agents.

Review 1. J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Review 2. J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Review 3. J-wave syndromes: Brugada and early repolarization syndromes.

Review 4. J wave syndromes as a cause of malignant cardiac arrhythmias.

5. Novel Therapeutic Strategies for the Management of Ventricular Arrhythmias Associated with the Brugada Syndrome.

Review 6. Brugada Syndrome: Clinical, Genetic, Molecular, Cellular, and Ionic Aspects.

Review 7. Pharmacological Therapy in Brugada Syndrome.

8. Beneficial Effects of Isoproterenol and Quinidine in the Treatment of Ventricular Fibrillation in Brugada Syndrome.

9. J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.